Purchase Order AG0521P160029
- Not listed
- The Office of Naval Research awarded a $3,855 firm fixed-price purchase order to Bio-Synthesis, Inc. (doing business as Dnaexam) on June 14, 2016, for custom DNA peptide synthesis. The contract, with an ultimate completion date of July 18, 2016, represents a straightforward procurement of specialized biological research materials. Bio-Synthesis, Inc., a Hispanic American-owned manufacturer based in Lewisville, Texas, specializes in advanced molecular synthesis services including peptides, RNA,...
- The Office of Naval Research awarded a firm fixed-price purchase order valued at $13,220 to Bio-Synthesis, Inc. (doing business as Dnaexam) on February 6, 2017, with an ultimate completion date of March 8, 2017. The contract, registered under PR# 69-4143-17, was issued without a set-aside designation and covers biologicals to be delivered to Lewisville, Texas. Bio-Synthesis, Inc., a Hispanic American-owned manufacturer of specialized biological research materials headquartered in Lewisville,...
- The Office of Naval Research awarded a $4,690 firm fixed-price purchase order (PR# 69-4164-17) to Bio-Synthesis, Inc., a Hispanic American-owned manufacturer specializing in custom biological research materials and synthesis services. The contract, which was not set aside for small businesses or other designated groups, was awarded on February 16, 2017, with an ultimate completion date of March 10, 2017. Bio-Synthesis will perform work at its facility in Lewisville, Texas, leveraging its...
- The Office of Naval Research (ONR) awarded a $3,400 purchase order to Bio-Synthesis, Inc., a Hispanic American-owned manufacturer specializing in custom peptide synthesis and advanced biological research materials. The firm fixed price contract, issued on January 15, 2014, with an ultimate completion date of February 5, 2014, was performed at Bio-Synthesis's facility in Lewisville, Texas. No set-aside designation was utilized for this award. Bio-Synthesis, Inc., which operates under the trade...
- The Office of Naval Research awarded a $4,375 purchase order to Bio-Synthesis, Inc. for custom CECA peptide synthesis services. The contract, issued on May 29, 2014, with an ultimate completion date of June 23, 2014, represents a firm fixed-price engagement with no set-aside designation. Bio-Synthesis, Inc., a Hispanic American-owned manufacturer based in Lewisville, Texas, and operating under the trade name Dnaexam, specializes in advanced biological research materials and custom molecular...
- This federal contract award, with the ID HHSN272201200589P, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Bio-Synthesis, Inc. (doing business as Dnaexam), a for-profit, Hispanic American-owned manufacturer. The contract, with a firm fixed price of $5,565.00, is for the delivery of drugs and biologicals. The contract does not have a set-aside designation and was awarded on July 18, 2012, with a...
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Bio-Synthesis, Inc. for chemical RNA ubermers and RNA transcription synthesis, valued at $5,210.00, with an award date of March 21, 2018 and completion date of March 20, 2019. Work is performed in Lewisville, Texas. Bio-Synthesis, Inc. is a Hispanic American-owned manufacturer of biological research materials.</p>
- The U.S. government awarded a purchase order contract to Biomatik USA, LLC for peptide synthesis services under Quote #SP5061729X12. This firm fixed price contract, awarded on August 11, 2015, carries a ceiling value of $4,350.40 and was completed by September 11, 2016. The contract was funded by a civilian agency within the Southeast Area and performed at Biomatik's facility located in Ottawa, Ontario, Canada. No set-aside designation was applied to this award. Biomatik USA, LLC is a biotech...
- This is a $10,585.00 firm fixed price purchase order awarded by the National Heart Lung and Blood Institute, a civilian agency, to Bio-Synthesis, Inc., a Hispanic American-owned manufacturer of goods. The contract is for the delivery of stapled NIX-derived peptides with derivatized N-termini to support the agency's ongoing study of the NIX/WIPI protein interaction, which began in March 2023. The award does not utilize a set-aside designation, and the ultimate completion date is June 24, 2025.
- The U.S. government awarded a firm fixed-price purchase order valued at $4,500 to Biomatik USA, LLC for the synthesis of 10 grams of chemically synthesized peptide (Quote #SP7010521R2). The contract, awarded on March 16, 2017, with an ultimate completion date of April 20, 2017, was funded by a civilian federal agency through its Southeast Area office. The work was to be performed at Biomatik's facility located in Ottawa, Ontario, Canada. No set-aside designation was applied to this...
Bio-Synthesis, Inc., operating as Dnaexam, received a $4,620 firm fixed-price purchase order from a civilian federal agency within the Pacific West Area for custom peptides. The contract, awarded on March 30, 2016, with an ultimate completion date of April 29, 2016, was performed at the company's Lewisville, Texas facility. No set-aside designation was applied to this award. Bio-Synthesis is a Hispanic American-owned, for-profit Subchapter S Corporation specializing in advanced biological research materials and custom synthesis services, with particular expertise in peptide, RNA, and nucleic acid synthesis for federal research institutions. The award reflects Bio-Synthesis's established technical capacity to deliver specialized molecular research materials supporting biomedical research initiatives. As a manufacturer registered in SAM.gov since 2002, the company has demonstrated consistent performance on federal contracts with the National Heart Lung and Blood Institute, National Institute of Allergy and Infectious Diseases, and National Institute on Drug Abuse, among other health-related research agencies. This purchase order represents a routine procurement of the company's core competency in custom peptide synthesis for federal scientific research purposes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 1 | Change Order | $55 | 4/6/16 | |
| Not listed | Not listed | $4.6k | 3/30/16 |